Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
View stock
VS
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24.5 billion of revenue in 2025 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
View stock

Stock highlights

Stock comparison highlights
Stock name
Quanome TechnologiesUnion Pacific
Last price
$0.33$304.20
Currency
USD
USD
$12M$180B
-23.56
-$0.37$12.82
1.860.95
0$5.56
01.88%
Sector
MobilityMobility
Employees
2728,658
Ticker
$QNME$UNP
Primary listing
NASDAQNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $QNME or $UNP on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.